Matthew Pratt-Hyatt, PhD, received his PhD in cellular and molecular biology from the University of Michigan. He is currently the Chief Scientific Officer at KBMO Molecular Diagnostics. He is focused on developing educational programs for those practitioners wanting to become experts in the testing, diagnosing and treatment of the negative health effects caused by toxic exposure. He specializes in developing tools that examine factors at the interface between genetics and toxicology. His work is bringing new insight into how genes and toxicants interact and how that may to lead to mental health disorders, chronic health issues, and metabolism disorders.